Immunic Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunic granted inducement equity awards covering 12,900 shares to three new employees on October 1, 2026, under its 2026 Inducement Equity Compensation Plan. The grants comply with Nasdaq Listing Rule 5635(c)(4) and vest with 25% on the first anniversary of hire, then monthly over 36 installments.
Key figures
- Vesting
- 25% on first anniversary of hire, remainder monthly over 36 installments
- Employees granted
- 3
- Inducement shares
- 12900
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.